NBY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NBY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2024-12-13), NovaBay Pharmaceuticals's 14-Day RSI is 37.85.
The industry rank for NovaBay Pharmaceuticals's 14-Day RSI or its related term are showing as below:
For the Biotechnology subindustry, NovaBay Pharmaceuticals's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, NovaBay Pharmaceuticals's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where NovaBay Pharmaceuticals's 14-Day RSI falls into.
The formula for calculating RSI is:
RSI | = | 100 | – | [ 100 | / | ( 1 + Average Gain | / | Average Loss )] |
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NovaBay Pharmaceuticals (AMEX:NBY) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Thank you for viewing the detailed overview of NovaBay Pharmaceuticals's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.
Tommy Law | officer: Interim CFO | 2000 POWELL STREET, SUITE 1150, EMERYVILLE CA 94608 |
Jeffrey Kunin | officer: President, DERMAdoctor, LLC | 4346 BELGIUM BLVD NW, RIVERSIDE MO 64150 |
Audrey Kunin | officer: Chief Product Officer | 4346 BELGIUM BLVD NW, RIVERSIDE MO 64150 |
Justin Hall | officer: General Counsel | 5980 HORTON STREET, SUITE 550, EMERYVILLE CA 94608 |
Yongxiang Zheng | director | NO.10, UNIT 1, LIJING VILLA, TIANZHU, SHUNYI DISTRICT, BEIJING F4 101316 |
Julie Garlikov | director | 2420 17TH STREET, SUITE 220, DENVER CO 80202 |
Andrew D. Jones | officer: CFO and Treasurer | 2000 POWELL STREET, SUITE 1150, EMERYVILLE CA 94608 |
Mijia Wu | director | SUITE 6C, BLDG 3, YOU YOU CENTURY PLAZA, NO 428 YANG GAO SOUTH ROAD, SHANGHAI F4 CHINA |
Jian Ping Fu | 10 percent owner | LEVEL 1, BLDG 1, GREENWOOD BUSINESS PARK, 301 BURWOOD HWY, BURWOOD C3 3125 |
Swan Sit | director | 95 JACKSON STREET, NEWTON MA 02459 |
Yenyou Zheng | director | 1055 WEST HASTINGS STREET, SUITE 1980, VANCOUVER A1 V6E 2E9 |
Xiaopei Wang | director | 2/44 FRANKLIN ROAD, DONCASTER EAST C3 3109 |
Jason Philip Raleigh | officer: Interim CFO and Treasurer | 2000 POWELL STREET, SUITE 1150, EMERYVILLE CA 94608 |
Pioneer Pharma (hong Kong) Co Ltd | 10 percent owner | FLAT 2605, 26/F TRENDY CENTRE, 682 CASTLE PEAK ROAD, KOWLOON K3 000000 |
Yanbin Liu | director | 27/F TWO EXCHANGE SQUARE, 8 CONNAUGHT PLACE, CENTRAL K3 00000 |
From GuruFocus
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 08-15-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.